Genedata Provides Expressionist Platform to U.S. Food and Drug Administration

Genedata, a leading provider of in silico solutions for the pharmaceutical and life sciences industries, today announced an agreement with the National Center for Toxicological Research of the U.S. Food and Drug Administration for the company’s Genedata Expressionist® biomarker discovery platform.

Source: Genedata AG